Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insmed Incorporated - Common Stock (NQ:INSM)

98.24 +0.62 (+0.64%)
Official Closing Price Updated: 4:15 PM EDT, Jul 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Insmed Incorporated - Common Stock

< Previous 1 2 3 4 5 6 Next >
Why Is Insmed (INSM) Stock Up 134% Today?
Insmed stock is up on Tuesday with heavy trading of INSM shares alongside positive results from a Phase 3 clinical trial. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are a hot topic as investors return to trading on Tuesday following the long holiday weekend! 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Where Insmed Stands With Analysts
Via Benzinga
Where Insmed Stands With Analysts
Via Benzinga
Why Insmed Stock Is Soaring Today
Investors applauded the company's latest clinical results. 
Via The Motley Fool
Dell To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
INSM Stock Earnings: Insmed Beats EPS, Misses Revenue for Q1 2024
INSM stock results show that Insmed beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
INSMED INC (NASDAQ:INSM) Reveals Intriguing Technical Aspects. Here's What You Need to Know.
Indications Suggest NASDAQ:INSM Could Be on the Verge of a Breakout. 
Via Chartmill
Insmed: Q1 Earnings Insights
Via Benzinga
Insmed's Return On Capital Employed Insights
Via Benzinga
A Preview Of Insmed's Earnings
Via Benzinga
Barclays Maintains Overweight Rating for Insmed: Here's What You Need To Know
Via Benzinga
Why Shares of Insmed Are Soaring This Week
The biotech company announced positive top-line trial results and received upgrades from analysts. 
Via The Motley Fool
Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Verb Technology Company, Inc. (NASDAQ: VERB) shares jumped 164% to $1.89 after the completed and launched a technology integration and strategic relationship with global social media platform... 
Via Benzinga
Insmed Is Making A Comeback — Why Shares Hit A Year High In Colossal Volume
The company is working on a treatment for a bacterial lung infection. 
Via Investor's Business Daily
Analyst Expectations for Insmed's Future
Via Benzinga
Analyst Ratings for Insmed
Via Benzinga
What 4 Analyst Ratings Have To Say About Insmed
Via Benzinga
Why Lung Disease Focused Stock Insmed Is Trading Higher Today?
Insmed Incorporated (NASDAQ: INSM) shares are trading higher after the company released topline results from its Phase 3 ARISE study of ARIKAYCE in patients with newly diagnosed or recurrent... 
Via Benzinga
Brady, Airbnb, Insmed And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones falling around 100 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2023
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Why Aptevo Therapeutics Shares Are Trading Higher By More Than 100%; Here Are 28 Stocks Moving Premarket
Gainers 
Via Benzinga
Coupa Software, Horizon Therapeutics And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
Upgrades 
Via Benzinga
Insmed's Return On Capital Employed Overview
Benzinga Pro data, Insmed (NASDAQ:INSM) reported Q3 sales of $67.73 million. Earnings fell to a loss of $131.15 million, resulting in a 37.12% decrease from last quarter. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.